Market Tracker

07/24 8:15am ET

Galectin Therapeutics Inc (NASDAQ:GALT)

2.18
Delayed Data
As of Jul 21
 -0.0107 / -0.49%
Today’s Change
0.49
Today|||52-Week Range
3.68
+122.49%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close2.19
Today’s open2.25
Day’s range2.15 - 2.34
Volume163,690
Average volume (3 months)362,815
Market cap$75.6M
Dividend yield--
Data as of 07/21/2017

Growth & Valuation

Earnings growth (last year)+13.64%
Earnings growth (this year)+26.32%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book23.50

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc+0.05+1.32%
VRMLVermillion Inc0.000.00%
TRILTrillium Therapeutic...-0.05-1.03%
BMRABiomerica Inc+0.07+2.53%
Data as of 07/21/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$21.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts